Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Depomedrol in XLIF Surgery
NCT03327272Phase 3Withdrawn
- Sponsor
- Rush University Medical Center
- Start
- May 2018
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in postoperative pain, neurologic injury, sponsored by Rush University Medical Center. Planned start May 2018; status: withdrawn.
02
Drugs
methylprednisolone
03
Conditions
postoperative painneurologic injury
Beyond the preview
Go deeper on NCT03327272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327272.